Answers are grounded in this paper and cite their sources.
The rectum is the site of 30% of all colorectal tumours. When contemplating neoadjuvant alternatives and surgical treatments, the rectum's position within the bony pelvis and its closeness to important tissues offer major therapeutic difficulties. Colorectal cancer survival times have improved as a result of advances in primary and adjuvant treatments. This paper aims to investigate the tumour regression grade (TRG) in rectal cancer patients, primarily if the interval of surgery after neoadjuvant chemoradiotherapy (nCRT) impacts tumour regression grade.
No takes yet. Share an insight, caveat, or question.
Tiang et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: